Clinical trial

Switch From Tenofovir to Raltegravir for Low Bone Mineral Density

NCT00939874

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-10-01

PhasePHASE4

Study timeline

Study start (unknown)2009-10-01Date precision: month

Registry last updated2015-06-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Osteopeniaunresolved

Osteoporosisunresolved

HIV Infectionsunresolved

Interventions

RaltegravirDRUG · verified · RxNorm: raltegravir

Sponsors & collaborators

St Vincent's Hospital, Sydneylead sponsor

Merck Sharp & Dohme LLCcollaborator

Holdsworth House Medical Practicecollaborator

The Alfredcollaborator

Mapped research locations

SydneyNew South Wales, Australia3 MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00939874 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.